ABCL logo

ABCL
AbCellera Biologics Inc

8,227
Mkt Cap
$1.03B
Volume
6.36M
52W High
$6.52
52W Low
$1.89
PE Ratio
-6.77
ABCL Fundamentals
Price
$3.90
Prev Close
$3.43
Open
$3.42
50D MA
$3.96
Beta
1.43
Avg. Volume
3.2M
EPS (Annual)
-$0.5533
P/B
1.21
Rev/Employee
$48,377.52
Loading...
Loading...
News
all
press releases
AbCellera Biologics (NASDAQ:ABCL) Trading Up 9.2% - Still a Buy?
AbCellera Biologics (NASDAQ:ABCL) Trading 9.2% Higher - Should You Buy...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
AbCellera Biologics (NASDAQ:ABCL) Cut to Sell at Wall Street Zen
Wall Street Zen lowered AbCellera Biologics from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·3d ago
News Placeholder
AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of "Hold" by Analysts
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL - Get Free Report) have been given a consensus rating of "Hold" by the seven brokerages that are presently covering the stock, Marketbeat reports. One...
MarketBeat·8d ago
News Placeholder
AbCellera Biologics (NASDAQ:ABCL) Upgraded at Wall Street Zen
Wall Street Zen upgraded AbCellera Biologics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·11d ago
News Placeholder
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...
Zero Hedge·14d ago
News Placeholder
Norges Bank Makes New $2.16 Million Investment in AbCellera Biologics Inc. $ABCL
Norges Bank bought a new stake in AbCellera Biologics Inc. (NASDAQ:ABCL - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission...
MarketBeat·27d ago
News Placeholder
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. A live audio webcast of the presentation may be...
Business Wire·29d ago
News Placeholder
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
AbCellera (Nasdaq: ABCL) today announced the appointment of Stephen Quake, D.Phil., to its Board of Directors as an independent director. Dr. Quake is a distinguished scientist, inventor, and...
Business Wire·2mo ago
News Placeholder
AbCellera Biologics (NASDAQ:ABCL) Posts Quarterly Earnings Results
AbCellera Biologics (NASDAQ:ABCL - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus...
MarketBeat·2mo ago
News Placeholder
AbCellera Biologics (NASDAQ:ABCL) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded shares of AbCellera Biologics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest ABCL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.